A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Giuseppe Curigliano |
| Publication date | March 14, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |